Oligonucleotide programs require coordinated expertise across chemistry, biology and DMPK to efficiently move promising candidates forward. This flyer introduces BioDuro’s integrated oligonucleotide discovery platform, bringing complementary capabilities together to support programs from sequence and molecule creation through biological evaluation and exposure assessment. Whether you are exploring new oligonucleotide candidates or advancing promising leads, the platform is designed to provide flexible support and decision-ready insights throughout discovery.

• Advancing Oligonucleotide Design: Broad synthesis and modification capabilities supporting diverse oligonucleotide formats and conjugate designs.
• Driving Biological Understanding: Functional screening and biological evaluation to help identify active and specific candidates and assess early developability.
• Supporting PK & Exposure Decisions: Specialized bioanalysis and exposure assessment to support pharmacokinetic and tissue-distribution studies and inform development decisions.

Download the full flyer to discover how BioDuro’s oligonucleotide platform can support your program with the capabilities and expertise needed to advance promising candidates.